戻る Agenda
Session 4 : Embrace the Challenge of eCOA Implementation to Drive Innovation and Deliver Exceptional Value
Session Chair(s)
Yuu Jincho, JD, MSc
Clinical Operation & Platforms /Data Management & Strategy, GlaxoSmithKline K.K., Japan
Megumi Kitayama
Specialist, Prime Research Institute For Medical RWD, Inc., Japan
Speaker(s)
The Current Industry Consensus on eCOA Implementation in Clinical Trials: Where are We, and Where should We be?
Scottie Kern
Executive Director, eCOA Consortium, Critical Path Institute, United States
Enhancing Patient Compliance in Clinical Trials: Automating eCOA Monitoring and Communication
Sudhansu Mishra
Associate Advisor - Clinical Data Strategist, Eli Lilly, United States
Challenges and Measures Identified from Extensive Experience in eCOA (ePRO) Implementation and Operation: A CRO's Perspective
Mitsuo Yoshimatsu
Clinical Data Management, Data Management, PPD-SNBL K.K., Japan